Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms

Trump signs executive order to encourage US drug manufacturing

U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.

Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns - iShares Biotechnology ETF (NASDAQ:IBB), AbbVie (NYSE:ABBV)

President Donald Trump signed an executive order Monday directing the FDA to accelerate approvals for domestic pharmaceutical manufacturing facilities as his administration prepares to announce new tariffs on imported medicines within two weeks

Trump signs executive order aimed at boosting US prescription drug manufacturing

President Donald Trump signed an executive order on Monday to cut down on the time it takes to approve U.S. pharmaceutical plants and to encourage more U.S. manufacturing of prescription drugs.

In the next two weeks, the tariffs will be implemented, it says. In addition, the US President signed an order to shorten approval procedures.

Trump Signs Order to Boost US Drug Manufacturing Ahead of Potential Pharma Tariffs

WASHINGTON—President Donald Trump on Monday signed an executive order aimed at boosting domestic production of prescription drugs and reducing America’s dependence on foreign pharmaceutical supply chains. The order directs the Food and Drug Administration (FDA) to streamline the approval process for domestic manufacturing facilities by eliminating unnecessary regulations and accelerating reviews. A key focus is cutting red tape within the permit…

Trump signs order in bid to boost pharma manufacturing in the U.S.

Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.